What Researchers Did
Researchers looked back at the medical records of 30 patients who experienced sudden sensorineural hearing loss to evaluate their diagnosis and treatment.
What They Found
The average age of patients was 48, and no specific cause was found for their hearing loss. All patients received corticosteroid treatment, with 7 of them also receiving hyperbaric oxygen therapy (HBOT). Recovery was noted in 71.4% of patients with moderate hearing loss and 69.2% of those with severe hearing loss.
What This Means for Canadian Patients
This study suggests that corticosteroids are a common treatment for sudden sensorineural hearing loss. While a small number of patients also received HBOT, the study does not clearly show its specific impact compared to corticosteroids alone. Canadian patients experiencing sudden hearing loss should consult an ear, nose, and throat (ENT) specialist to discuss appropriate treatment options.
Canadian Relevance
No direct Canadian connection identified, as this was not a Canadian study and sudden sensorineural hearing loss is not a Health Canada-recognized indication for HBOT.
Study Limitations
This was a small retrospective study with only 30 patients, making it difficult to draw strong conclusions or clearly determine the specific benefits of hyperbaric oxygen therapy when combined with corticosteroids.